2024 / 03

Next Paper
DOI: 10.24075/brsmu.2024.025

ORIGINAL RESEARCH

Orphan diseases in the republic of North Ossetia–Alania: structure, population genetic features, issues and prospects

Zinchenko RA1, Tebieva IS2,3, Gabisova YuV3, Shukan EYu4, Khokhova AV2,3, Marakhonov AV1, Kutsev SI1
About authors

1 Bochkov Research Center for Medical Genetics, Moscow, Russia

2 North-Ossetian State Medical Academy, Vladikavkaz, Russia

3 Republican Children’s Clinical Hospital, Vladikavkaz, Russia

4 Semashko National Research Institute of Public Health, Moscow, Russia

Correspondence should be addressed: Rena A. Zinchenko
Moskvorechye, 1, 115522, Moscow, Russia; ur.liam@oknehcnizaner

About paper

Funding: the study was supported as part of the State Assignment of the Research Centre for Medical Genetics and the Ministry of Health of the Republic of North Ossetia–Alania.

Author contribution: Zinchenko RA, Tebieva IS, Gabisova YuV, Khokhova AV — patient examination, making the diagnosis, obtaining the informed consent, and biomaterial collection; Shukan EYu — acquisition of data on the number of patients; Zinchenko RA, Tebieva IS, Kutsev SI — study planning, statistical analysis, manuscript writing; Marakhonov AV — analysis of molecular genetic tests; Tebieva IS, Marakhonov AV, Zinchenko RA — editing; Zinchenko RA, Kutsev SI — general management, editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Research Centre for Medical Genetics (protocol No. 5 dated 20 December 2010), it was compliant with the Good Clinical Practice and evidence-based medicine standards. All patients submitted the informed consent to participation in the study.

Received: 2024-05-08 Accepted: 2024-06-02 Published online: 2024-06-26
|
  1. Ferreira CR. The burden of rare diseases. Am J Med Genet. 2019; 179A: 885–92. DOI:10.1002/ajmg.a.61124
  2. Wakap NS, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. 2020, 28, 165–173. Available from: https://doi.org/10.1038/s41431-019-0508-0
  3. Vasileva TP, Zinchenko RA, Komarov IA, Krasil'nikova EYu, Aleksandrova OYu, Konovalov OE, i dr. Rasprostranennost' i voprosy diagnostiki redkih (orfannyh) zabolevanij sredi detskogo naselenija Rossijskoj Federacii. Pediatrija. Zhurnal imeni G. N. Speranskogo. 2020; 99 (4): 229–37. DOI: 10.24110/0031-403X-2020-99-4-229-237. Russian.
  4. Zinchenko RA, Vasileva TP, Konovalov OE, Komarov IA, Krasilnikova EYu, Aleksandrova OYu, i dr. Invalidnost' i letal'nost' pri redkih (orfannyh) zabolevanijah sredi detskogo naselenija Rossijskoj Federacii. Pediatrija. Zhurnal imeni G. N. Speranskogo. 2020; 99 (3): 271–8. DOI: 10.24110/0031-403X-2020-99-3-271-278. Russian.
  5. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis Res. 2012; 1 (1): 3–9. Available from: https://doi.org/10.5582/irdr.2012.v1.1.3 PMID:25343064 .
  6. Shafie AA, Supian A, Ahmad Hassali MA, Ngu L-H, Thong M-K, Ayob H, et al. Rare disease in Malaysia: Challenges and solutions. PLoS ONE. 2020; 15 (4): e0230850. Available from: https://doi.org/10.1371/journal.pone.0230850
  7. Chiu AТ, Chung CC, Wong WH, Lee SL, Chung BH. Healthcare burden of rare diseases in Hong Kong — adopting ORPHAcodes in ICD-10 based healthcare administrative datasets. Orphanet Journal of Rare Diseases. 2018; 13 (1): 147. Available from: https://doi.org/10.1186/s13023-018-0892-5
  8. Liu Y, Qian S. Current situation and prospect for the diagnosis and treatment of pediatric critical rare diseases in China. Pediatric Investigation. 2024; 8 (1): 66–71. Available from: https://doi.org/10.1002/ped4.12419
  9. Taruscio D, Baynam G, Cederroth H, Groft S, Klee E, Kasaki K, et al. The Undiagnosed Diseases Network International: Five years and more! Mol Genet Metab. 2020; 129 (4): 243–54.
  10. Macnamara EF, D’Souza P. Undiagnosed Diseases Network, Tifft CJ. The undiagnosed diseases program: Approach to diagnosis. Transl Sci Rare Dis. 2019; 4 (3–4): 179–88.
  11. Vasichkina ES, Kostareva AA. Redkie i neizvestnye zabolevanija — sovremennyj trend mediciny. Rossijskij zhurnal personalizirovannoj mediciny. 2022; 2 (2): 72–83. DOI: 10.18705/2782-3806-2022-2-2-72-83. Russian.
  12. Schoch K, Esteves C, Bican A, Spillman R, Cope H, McConkie- Rosell A, et al. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science. Genet Med. 2021; 23 (2): 259–71.
  13. Lopez-Martin E, Martinez-Delgado B, Berme-jo-Sanchez E, Alonso J. SpainUDP: The Spanish Undiagnosed Rare Diseases Program. Int J Environ Res Public Health. 2018; 15 (8): 1746.
  14. Takahashi Y, Mizusawa H. Initiative on Rare and Undiagnosed Disease in Japan. JMAJ. 2021; 4 (2): 112–8.
  15. Kim SY, Lim BC, Lee JS, Kim WJ, Lim H, Ko JM, et al. The Korean undiagnosed diseases program: lessons from a one-year pilot project. Orphanet J Rare Dis. 2019; 14: 68.
  16. Yang L, Su C, Lee AM, et al. Focusing on rare diseases in China: are we there yet? Orphanet J Rare Dis. 2015; 10: 142.
  17. Genomika Anglii. Protokol proekta «100 000 genomov». 2017 g. Available from: https://figshare.com/articles/journal_contribution/GenomicEnglandProtocol_pdf/4530893/4
  18. Smedley D, Smith KR, Martin A, Thomas EA, McDonagh EM, Cipriani V. 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report. N Engl J Med. 2021; 385 (20): 1868–80. DOI: 10.1056/NEJMoa2035790. PMID: 34758253; PMCID: PMC7613219.
  19. Köhler S, Carmody L, Vasilevsky N, Jacobsen J, Danis D, Gourdine J, et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019; 47: D1018–D1027. PubMed: 30476213.
  20. Martin AR, Williams E, Foulger RE, Leigh S. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019; 51: 1560–5. PubMed: 31676867.
  21. Rowlands C, Thomas HB, Lord J, Wai H, Arno G, Beaman G, et al. Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders. Sci Rep. 2021; 11: 20607. PubMed: 34663891.
  22. Available from: www.rosminzdrav.ru/documents/8048-perechen-redkih- orfannyhzabolevaniy.
  23. Shashel VA, Firsova VN, Trubilina MM, Podporina LA, Firsov NA. Orfannye zabolevanija i svjazannye s nimi problemy. Medicinskij vestnik Juga Rossii. 2021; 12 (2): 28–35. DOI: 10.21886/2219-8075-2021-12-2-28-35. Russian.
  24. Available from: http://komitet-zdorov.duma.gov.ru/about/ekspertnye-sovety/orfany
  25. Available from: www.orpha.net
  26. Klinicheskie rekomendacii. Klassicheskaja fenilketonurija i drugie vidy giperfenilalaninemii. 2020. Available from: https://cr.minzdrav.gov.ru/recomend/482
  27. Tebieva IS, Mishakova PV, Gabisova YV, Khokhova AV, Kaloeva TG, Marakhonov AV, et al. Genetic landscape and clinical features of hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the PAH Gene. Int J Mol Sci. 2024, 25, 4598. Available from: https://doi.org/10.3390/ ijms25094598.
  28. Tebieva IS, Gabisova YuV, Zinchenko RA. Rezul'taty 15-letnego neonatal'nogo skrininga v Respublike Severnaja Osetija-Alanija. Medicinskaja genetika. 2023; 22 (2): 40–47. https://doi.org/10.25557/2073-7998.2023.02.40-47. Russian.
  29. Tebieva IS, Getoeva ZK, Petrova NV, Gabisova YuV, Dzhadzhieva MYu, Zinchenko RA, Dzheliev ISh. Mukoviscidoz: jetiologija, patogenez, klinika, rezul'taty neonatal'nogo skrininga i geneticheskie aspekty v respublike Severnaja Osetija — Alanija. Pediatrija. Zhurnal im. G. N. Speranskogo. 2021; (100) 1: 222–8. DOI: 10.24110/0031-403X-2021-100-1-222-228. Russian.
  30. Ajupova GR, Minniahmetov IR, Husainova RI. Mukoviscidoz: sovremennye vozmozhnosti diagnostiki i lechenija na osnove molekuljarnogo patogeneza. Medicinskaja genetika. 2022; 21 (9): 22–27. Russian.
  31. Klinicheskie rekomendacii po kistoznomu fibrozu (mukoviscidozu). 2021; Available from: https://cr.minzdrav.gov.ru/recomend/372_2. Russian.
  32. Movsisjan GB, Roppelt AA, Juhacheva DV, Shherbina AYu, Smetanina NS, Savostjanov KV, i dr. Redkoe nabljudenie reakcii giperchuvstvitel'nosti na preparaty dlja fermentnoj zamestitel'noj terapii u rebenka s bolezn'ju Goshe 3-go tipa. Pediatrija. Zhurnal im. G. N. Speranskogo. 2022; 101 (2): 113–21. Russian.